Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.66% | -68.10% | 42.33% | 10.37% | -10.89% |
| Total Depreciation and Amortization | -43.16% | -2.49% | -14.01% | 13.22% | 0.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.86% | -13.53% | -14.25% | -18.83% | -26.84% |
| Change in Net Operating Assets | -3,552.89% | 83.09% | -121.99% | 3,028.85% | -51.06% |
| Cash from Operations | -57.09% | -56.90% | -12.90% | 48.41% | -18.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | 996.11% | -- | -100.00% | -49.82% | -12.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 441.28% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -355.73% | -205.73% | 3.09% | 6.09% | -263.16% |
| Cash from Financing | 613.15% | 6,697.13% | -129.62% | -49.93% | -30.75% |
| Foreign Exchange rate Adjustments | -100.00% | -452.94% | 38.55% | 57.87% | -373.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,243.80% | 152.43% | -32.28% | 48.32% | -34.25% |